What is the generic name?

BROLUCIZUMAB

What is the Trade Name for BROLUCIZUMAB?

BEOVU

What are the Indications for BROLUCIZUMAB?

• 1 INDICATIONS AND USAGE BEOVU ¬Æ is indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD). BEOVU is a human vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of Neovascular (Wet) Age-Related Macular Degeneration (AMD) ( 1 ).

References: https://open.fda.gov/